CPA
CDMO

Capital Performance Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Capital Performance Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-80
Closed -$910 – 2862
2024
Q3 		$910 Buy
+80
New +$803 ﹤0.01% 1946

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Capital Performance Advisors's CDMO Position: Q4 2024 in Review

Capital Performance Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 80 shares — an estimated $910 sold.

Capital Performance Advisors first reported a position in CDMO in Q3 2024 and held it in 1 quarter. The position peaked at $910 in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Capital Performance Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 80 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $910.
  • Capital Performance Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Avid Bioservices, Inc. Common Stock position peaked at $910 in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.